Tecentriq 1,200 MG/20 ML vial 20ML
Ended Awarded Last action
- Contract number
- SPE2DR26FSQP0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,547
Award facts
- Contract value 100% obligated
- $26,546.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $26,546.92 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 1,200 mg/20 ml vials of Tecentriq, a specialty oncology therapeutic. The delivery order, issued without set-aside designation on December 9, 2025, is scheduled for completion by December 31, 2025, and will be performed at DMS Pharmaceutical Group's Park Ridge facility. This award represents a single delivery order issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative.
DMS Pharmaceutical Group holds a single-award IDC valued at $499.999 billion under the PPV-G GEN V program, which was established on November 13, 2025, with an ultimate completion date of December 31, 2036. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to provide the Department of Defense with comprehensive pharmaceutical supply chain support, including branded and generic prescription drugs, biologics, and medical consumables to support military healthcare facilities worldwide. As a certified small business contractor with established federal pharmaceutical supply chain expertise, DMS Pharmaceutical Group has demonstrated consistent performance across numerous delivery orders issued by the Defense Logistics Agency, positioning the company as a critical supplier for Department of Defense medical operations.
Quick answers
Who was awarded contract SPE2DR26FSQP0?
SPE2DR26FSQP0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FSQP0 worth?
The government has obligated $26,547 on SPE2DR26FSQP0.
Is contract SPE2DR26FSQP0 an order under another contract?
Yes. SPE2DR26FSQP0 is a delivery order under SPE2DR25D9348, an indefinite delivery contract.
Was contract SPE2DR26FSQP0 competed?
The extent of competition for SPE2DR26FSQP0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award